文献
J-GLOBAL ID:201702248369635264
整理番号:17A0358752
急性心不全のアジア人患者の標準的治療に追加した場合のセレラキシンの有効性,安全性,および耐容性の評価
Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial
著者 (13件):
Sato Naoki
(Cardiology and Intensive Care Unit, Nippon Medical School, Musashi-Kosugi Hospital, Kawasaki, Japan)
,
Lam Carolyn S.P.
(National Heart Centre Singapore and Duke-NUS, Singapore)
,
Teerlink John R.
(University of California, San Francisco, and San Francisco Veterans Affairs Medical Center, Los Angeles, California)
,
Greenberg Barry H.
(Division of Cardiology, University of California, San Diego, La Jolla, California)
,
Tsutsui Hiroyuki
(Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan)
,
Oh Byung-Hee
(Department of Internal Medicine, Seoul National University, College of Medicine, Seoul, South Korea)
,
Zhang Jian
(Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China)
,
Lefkowitz Martin
(Novartis Pharmaceuticals Corporation, East Hanover, New Jersey)
,
Hua Tsushung A.
(Novartis Pharmaceuticals Corporation, East Hanover, New Jersey)
,
Holbro Thomas
(Novartis Pharma, Basel, Switzerland)
,
Marshood Miriam
(Novartis Pharmaceuticals Corporation, East Hanover, New Jersey)
,
Wang Xing Li
(Novartis Pharmaceuticals Corporation, East Hanover, New Jersey)
,
Ge Junbo
(Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China)
資料名:
Journal of Cardiac Failure
(Journal of Cardiac Failure)
巻:
23
号:
1
ページ:
63-71
発行年:
2017年01月
JST資料番号:
W1342A
ISSN:
1071-9164
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)